| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Ian Ford BA (Hons) ACA, F.C.A. CEO | XFRA Exchange | GB00B0923P27 ISIN |
| United Kingdom Country | 2 Employees | - Last Dividend | - Last Split | - IPO Date |
Provexis plc operates as a pioneering entity focused on the invention, licensing, and commercial distribution of functional foods, medical foods, and dietary supplements with a global outreach. Established in 1999 and headquartered in Reading, the United Kingdom, the company has carved a niche in the health and wellness sector by developing innovative products aimed at improving cardiovascular health and overall well-being. It primarily caters to consumer needs through comprehensive distribution channels, including partnerships with distributors and online retail platforms, ensuring wide accessibility to its health-boosting offerings.
The product has been refined into syrup and powder formulations, enabling versatile applications across a myriad of food, beverage, and dietary supplement products. Its adaptability and efficacy make it a sought-after ingredient for health-conscious consumers and brands alike.
Through its innovative approach to product development and keen focus on heart health, Provexis plc offers solutions that align with the growing consumer demand for natural and effective dietary supplements. The company leverages both direct and indirect sales channels to reach a global audience, ensuring that its health-enhancing products are accessible to a wide customer base.